In the LabGene therapy’s promising start came to a crashing halt. Will CRISPR meet the same fate? By Retro ReportApril 10, 2018 Reprints The Code is a three-part video series investigating the roots of today’s most promising genetic technologies About the Author Reprints Retro Report @RetroReport
Biotech Matthew Herper STAT Plus: Novartis data set up multibillion-dollar battle over breast cancer drugs
Pharmalot Ed Silverman STAT Plus: Ohio attorney general accuses pharmacy benefit managers of drug price fixing
Health Tech Mohana Ravindranath and Casey Ross STAT Plus: Cerebral and other telehealth startups face new legal and regulatory challenges over ad models
Health Tech Brittany Trang and Casey Ross STAT Plus: ‘We’re getting much more aggressive’: Microsoft’s Nuance adds GPT-4 AI to its medical note-taking tool
A STAT Investigation Casey Ross and Bob Herman STAT Plus: Denied by AI: How Medicare Advantage plans use algorithms to cut off care for seniors in need
